Manufacturers Life Insurance Company, The Madrigal Pharmaceuticals, Inc. Transaction History
Manufacturers Life Insurance Company, The
- $102 Billion
- Q2 2024
A detailed history of Manufacturers Life Insurance Company, The transactions in Madrigal Pharmaceuticals, Inc. stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 35,678 shares of MDGL stock, worth $7.74 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
35,678
Previous 30,741
16.06%
Holding current value
$7.74 Million
Previous $8.21 Million
21.76%
% of portfolio
0.01%
Previous 0.01%
Shares
31 transactions
Others Institutions Holding MDGL
# of Institutions
299Shares Held
22MCall Options Held
757KPut Options Held
370K-
Janus Henderson Group PLC London, X02.49MShares$539 Million0.38% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.06MShares$446 Million7.86% of portfolio
-
Baker Bros. Advisors LP New York, NY1.97MShares$428 Million7.35% of portfolio
-
Rtw Investments, LP New York, NY1.92MShares$416 Million8.96% of portfolio
-
John Paulson Paulson & Co. Inc. | New York, Ny1.85MShares$401 Million39.74% of portfolio
About MADRIGAL PHARMACEUTICALS, INC.
- Ticker MDGL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 17,103,400
- Market Cap $3.71B
- Description
- Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...